Generic semaglutide race hinges on API supply as china leads, global peptide demand to hit 99,000 kg by 2030: Goldman Sachs
New Delhi [India], June 7 (ANI): The speed of semaglutide genericisation and GLP-1 pricing after 2031/32 will likely depend less…
